MarketCap
Facebook
X
TelegramQuarterly report 2022-Q1
added 05-23-2026
Global Cord Blood Corporation Cash and Cash Equivalents 2011-2026 | CO
Annual Cash and Cash Equivalents Global Cord Blood Corporation
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 6.66 B | 6.08 B | 5.47 B | 5 B | 4.25 B | 3.51 B | 3.01 B | 2.44 B | 1.88 B | 1.49 B | 794 M | 611 M | 281 M | 161 M |
All numbers in CNY currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 6.66 B | 161 M | 2.97 B |
Quarterly Cash and Cash Equivalents Global Cord Blood Corporation
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | 2010-Q1 | 2009-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | 6.66 B | - | 6.39 B | 6.39 B | 6.08 B | - | 5.73 B | 5.37 B | 5.47 B | - | 5.37 B | 4.61 B | 5 B | - | 4.61 B | 3.93 B | 4.25 B | - | 3.93 B | 3.14 B | 3.51 B | - | 3.14 B | 2.67 B | 3.01 B | - | 2.67 B | 2.16 B | 2.44 B | - | 2.16 B | - | 1.88 B | - | 1.67 B | 1.67 B | 1.49 B | - | 1.32 B | 1.32 B | 794 M | 717 M | 717 M | 636 M | 611 M | 281 M | 161 M |
All numbers in CNY currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 6.66 B | 161 M | 3.11 B |
Cash and Cash Equivalents of other stocks in the Diagnostics research industry
| Issuer | Cash and Cash Equivalents | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Enzo Biochem
ENZ
|
52.4 M | - | -8.98 % | $ 14.8 K |  USA |
 |
Centogene N.V.
CNTG
|
19.1 M | - | -6.23 % | $ 30.6 M |  Germany |
 |
Heska Corporation
HSKA
|
157 M | - | - | $ 1.31 B | USA |
 |
Celcuity
CELC
|
166 M | $ 89.18 | -3.56 % | $ 4.17 B | USA |
|
Akumin
AKU
|
59.4 M | - | -17.87 % | $ 25.9 M |  Canada |
 |
Co-Diagnostics
CODX
|
11.9 M | $ 5.14 | -10.76 % | $ 6.84 M | USA |
 |
Fulgent Genetics
FLGT
|
50.2 M | $ 19.15 | -1.82 % | $ 589 M | USA |
 |
Castle Biosciences
CSTL
|
117 M | $ 21.36 | -1.13 % | $ 619 M | USA |
 |
Aspira Women's Health
AWH
|
1.76 M | - | -6.19 % | $ 10.5 M | USA |
 |
Accelerate Diagnostics
AXDX
|
15.1 M | - | -61.36 % | $ 2.46 M | USA |
 |
Guardant Health
GH
|
378 M | $ 127.58 | -4.12 % | $ 16 B | USA |
 |
Biocept
BIOC
|
12.9 M | - | -13.05 % | $ 7.29 M | USA |
 |
Interpace Biosciences
IDXG
|
2.5 M | $ 1.79 | 2.29 % | $ 7.92 M | USA |
 |
Illumina
ILMN
|
1.42 B | $ 162.64 | -3.23 % | $ 25.2 B | USA |
 |
CareDx, Inc
CDNA
|
65.4 M | $ 22.39 | -3.16 % | $ 1.19 B | USA |
 |
Chembio Diagnostics
CEMI
|
18.2 M | - | 0.22 % | $ 16.8 M | USA |
 |
Check-Cap Ltd.
CHEK
|
2 K | - | - | $ 9.42 M |  Israel |
 |
ICON Public Limited Company
ICLR
|
647 M | $ 149.96 | -1.86 % | $ 11.8 B |  Irlanda |
 |
HTG Molecular Diagnostics
HTGM
|
12.2 M | - | -20.0 % | $ 1.06 M | USA |
 |
Lantheus Holdings
LNTH
|
359 M | $ 102.59 | -0.22 % | $ 6.92 B | USA |
 |
Genetic Technologies Limited
GENE
|
1.02 M | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
176 M | - | 0.12 % | $ 80.1 M |  China |
 |
DermTech
DMTK
|
36.7 M | - | -11.32 % | $ 2.94 M | USA |
 |
NeoGenomics
NEO
|
160 M | $ 10.96 | -3.14 % | $ 1.4 B | USA |
 |
Charles River Laboratories International
CRL
|
214 M | $ 183.85 | -1.06 % | $ 9.11 B | USA |
 |
Natera
NTRA
|
1.08 B | $ 218.2 | -1.76 % | $ 29.8 B | USA |
 |
Pacific Biosciences of California
PACB
|
63.7 M | $ 1.46 | -10.74 % | $ 438 M | USA |
 |
Medpace Holdings
MEDP
|
497 M | $ 455.55 | -0.68 % | $ 13.1 B | USA |
 |
Mettler-Toledo International
MTD
|
66.9 M | $ 1 155.01 | -2.16 % | $ 23.8 B |  Schweiz |
 |
Exact Sciences Corporation
EXAS
|
956 M | - | - | $ 19.8 B | USA |
 |
Myriad Genetics
MYGN
|
150 M | $ 4.64 | -0.96 % | $ 430 M | USA |
 |
National Research Corporation
NRC
|
4.14 M | $ 19.52 | -1.14 % | $ 437 M | USA |
 |
Personalis
PSNL
|
124 M | $ 11.02 | -8.93 % | $ 983 M | USA |
 |
Koninklijke Philips N.V.
PHG
|
2.79 B | $ 26.17 | 0.67 % | $ 24.8 B |  Niderland |
 |
Senseonics Holdings
SENS
|
40.2 M | $ 6.7 | -4.49 % | $ 280 M | USA |
 |
QIAGEN N.V.
QGEN
|
598 M | - | - | $ 10.6 B | Niderland |
 |
Soleno Therapeutics
SLNO
|
70.1 M | - | - | $ 2.69 B | USA |
 |
Biomerica
BMRA
|
2.4 M | $ 2.21 | 2.79 % | $ 5.08 M | USA |
 |
Laboratory Corporation of America Holdings
LH
|
532 M | $ 265.31 | 1.61 % | $ 22.1 B | USA |
 |
Twist Bioscience Corporation
TWST
|
183 M | $ 69.92 | -5.43 % | $ 4.18 B | USA |
 |
Thermo Fisher Scientific
TMO
|
9.85 B | $ 474.37 | -1.6 % | $ 179 B | USA |
 |
Trinity Biotech plc
TRIB
|
5.17 M | $ 0.72 | 5.2 % | $ 259 M | Irlanda |
 |
Motus GI Holdings
MOTS
|
4.96 M | - | -34.28 % | $ 263 K | Israel |
 |
Waters Corporation
WAT
|
588 M | $ 366.13 | -2.74 % | $ 21.8 B | USA |
 |
Neogen Corporation
NEOG
|
129 M | $ 8.99 | -1.48 % | $ 1.95 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
420 M | $ 200.67 | 2.3 % | $ 22.3 B | USA |